Trial Profile
A Retrospective, Cohort study to evaluate the efficacy and safety of Treprostinil in infants with Pulmonary Hypertension secondary to Congenital Diaphragmatic Hernia (CDH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- 25 May 2018 New trial record
- 18 May 2018 Results published in the Journal of Pediatrics